Saskia Willenbrock

698 citations

34 papers · 565 indexed · h-index 17

Equine top 10%
Clinical Biochemistry top 10%
Cancer Research
- MicroRNA in disease regulation 3
Biophysics top 10%
Biotechnology
Genetics
- Virus-based gene therapy research 8
Pulmonary and Respiratory Medicine
- Veterinary Oncology Research 7
Immunology
- Immunotherapy and Immune Responses 5
Computational Mechanics
- Laser Material Processing Techniques 4
Electrical and Electronic Engineering
- Electrohydrodynamics and Fluid Dynamics 3
Molecular Biology
- RNA Interference and Gene Delivery 3
Oncology
- Cancer Cells and Metastasis 3

Co-authors: Hugo Murua Escobar Ingo Nölte Alexander Heisterkamp Siegfried Wagner Jörn Bullerdiek Anaclet Ngezahayo N. Eberle Christian Junghanß
Cited by: Equine Clinical Biochemistry Cancer Research
Journals: PLoS ONE (3 papers)International Journal of Molecular Sciences (2 papers)Optics Express (1 paper)
Partner nations: Germany Austria United States

In The Last Decade

Saskia Willenbrock

34 papers receiving 553 citations

Peers

Countries citing papers authored by Saskia Willenbrock

Since Specialization

Citations

This map shows the geographic impact of Saskia Willenbrock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saskia Willenbrock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saskia Willenbrock more than expected).

Fields of papers citing papers by Saskia Willenbrock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saskia Willenbrock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saskia Willenbrock. The network helps show where Saskia Willenbrock may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Saskia Willenbrock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Saskia Willenbrock Line = papers co-authored together Saskia Willenbrock links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The effect of dichloroacetate in canine prostate adenocarcinomas and transitional cell carcinomas in vitro International Journal of Oncology ·Tatjana Paola Harting,Mandy Stubbendorff,Saskia Willenbrock,Siegfried Wagner,Patrik Schadzek,Anaclet Ngezahayo,Hugo Murua Escobar,Ingo Nölte	2016	21
2	Hormone Receptor Expression Analyses in Neoplastic and Non-Neoplastic Canine Mammary Tissue by a Bead Based Multiplex Branched DNA Assay: A Gene Expression Study in Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Samples PLoS ONE ·Annika Mohr,Florenza Lüder Ripoli,Susanne Conradine Hammer,Saskia Willenbrock,Marion Hewicker‐Trautwein,Zdzisław Kiełbowicz,Hugo Murua Escobar,Ingo Nölte	2016	10
3	Characterization of nanoparticle mediated laser transfection by femtosecond laser pulses for applications in molecular medicine Journal of Nanobiotechnology ·Markus Schomaker,Dag Heinemann,Stefan Kalies,Saskia Willenbrock,Siegfried Wagner,Ingo Nölte,Tammo Ripken,Hugo Murua Escobar,Heiko Meyer,Alexander Heisterkamp	2015	53
4	Influences of age and sex on leukocytes of healthy horses and their ex vivo cytokine release Veterinary Immunology and Immunopathology ·Christiane L. Schnabel,P Steinig,H. J. Schuberth,Mirja Koy,Bettina Wagner,B. Wittig,Christiane Juhls,Saskia Willenbrock,Hugo Murua Escobar,Peter Jaehnig,Karsten Feige,Jessika‐M. V. Cavalleri	2015	14
5	Generation and Characterisation of a Canine EGFP-HMGA2 Prostate Cancer In Vitro Model PLoS ONE ·Saskia Willenbrock,Siegfried Wagner,Nicola Reimann-Berg,Mohammed Moulay,Marion Hewicker‐Trautwein,Ingo Nölte,Hugo Murua Escobar	2014	7
6	HMGA1 and HMGA2 expression and comparative analyses of HMGA2, Lin28and let-7 miRNAs in oral squamous cell carcinoma BMC Cancer ·Katharina A. Sterenczak,A. Eckardt,Andreas Kampmann,Saskia Willenbrock,N. Eberle,Florian Länger,Sven Kleinschmidt,Marion Hewicker‐Trautwein,Hans Kreipe,Ingo Nölte,Hugo Murua Escobar,Nils Claudius Gellrich	2014	28
7	Comparison of non-coding RNAs in human and canine cancer Frontiers in Genetics ·Siegfried Wagner,Saskia Willenbrock,Ingo Nölte,Hugo Murua Escobar	2013	24
8	Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer BMC Cancer ·Katharina A. Sterenczak,Martin Meier,Silke Glage,Matthias C. Meyer,Saskia Willenbrock,Patrick Wefstaedt,Martina Dorsch,Jörn Bullerdiek,Hugo Murua Escobar,Hans J. Hedrich,Ingo Nölte	2012	21
9	Authentication of Primordial Characteristics of the CLBL-1 Cell Line Prove the Integrity of a Canine B-Cell Lymphoma in a Murine In Vivo Model PLoS ONE ·Barbara C. Rütgen,Saskia Willenbrock,Nicola Reimann-Berg,Ingrid Walter,Andrea Fuchs‐Baumgartinger,Siegfried Wagner,Boris Kovačic,Sabine E. Essler,Ilse Schwendenwein,Ingo Nölte,Armin Saalmüller,Hugo Murua Escobar	2012	19
10	Enhanced protocol for CD14+ cell enrichment from equine peripheral blood via anti‐human CD14 mAb and automated magnetic activated cell sorting Equine Veterinary Journal ·Ma Carmen Durán-Ruiz,Saskia Willenbrock,Regina Carlson,Karsten Feige,Ingo Nölte,Hugo Murua Escobar	2012	7
11	TNF-α induced secretion of HMGB1 from non-immune canine mammary epithelial cells (MTH53A) Cytokine ·Saskia Willenbrock,Olga Braun,Judith Baumgart,Sandra Lange,Christian Junghanß,Alexander Heisterkamp,Ingo Nölte,Jörn Bullerdiek,Hugo Murua Escobar	2011	19
12	Comparison of nanoparticle-mediated transfection methods for DNA expression plasmids: efficiency and cytotoxicity Journal of Nanobiotechnology ·María Carolina Durán,Saskia Willenbrock,Annette Barchanski,Jessika-M.V. Müller,Arianna Maiolini,Jan T. Soller,Stephan Barcikowski,Ingo Nölte,Karsten Feige,Hugo Murua Escobar	2011	18
13	Cytogenetic Analysis of CpG-Oligonucleotide DSP30 plus Interleukin-2-Stimulated Canine B-Cell Lymphoma Cells Reveals the Loss of One X Chromosome as the Sole Abnormality Cytogenetic and Genome Research ·Nicola Reimann-Berg,Hugo Murua Escobar,Yvonne Kiefer,R. Mischke,Saskia Willenbrock,N. Eberle,Ingo Nölte,Jörn Bullerdiek	2011	2
14	Generation of recombinant antibody fragments that target canine dendritic cells by phage display technology Veterinary and Comparative Oncology ·Jenny Fitting,Doreen Killian,Christian Junghanß,Saskia Willenbrock,Hugo Murua Escobar,Sandra Lange,Ingo Nölte,Stefan Barth,Mehmet Kemal Tur	2010	10
15	Two New Cases of Polysomy 13 in Canine Prostate Cancer Cytogenetic and Genome Research ·Nicola Reimann-Berg,Saskia Willenbrock,Hugo Murua Escobar,N. Eberle,I. Gerhauser,R. Mischke,Jörn Bullerdiek,Ingo Nölte	2010	14
16	Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms Gene ·Katharina A. Sterenczak,Saskia Willenbrock,Matthias Barann,Markus Klemke,Jan T. Soller,N. Eberle,Ingo Nölte,Jörn Bullerdiek,Hugo Murua Escobar	2008	41
17	Quantified femtosecond laser based opto-perforation of living GFSHR-17 and MTH53 a cells Optics Express ·Judith Baumgart,Willem Bintig,Anaclet Ngezahayo,Saskia Willenbrock,Hugo Murua Escobar,W. Ertmer,Holger Lubatschowski,Alexander Heisterkamp	2008	69
18	Genomic characterisation, chromosomal assignment and in vivo localisation of the canine High Mobility Group A1 (HMGA1) gene BMC Genetics ·Claudia Beuing,Jan T. Soller,Michaela Muth,Sigfried Wagner,G. Dolf,C. Schelling,Andreas Richter,Saskia Willenbrock,Nicola Reimann-Berg,Susanne Winkler,Ingo Nölte,Jörn Bullerdiek,Hugo Murua Escobar	2008	2
19	Establishing an in vivo model of canine prostate carcinoma using the new cell line CT1258 BMC Cancer ·M. Fork,Hugo Murua Escobar,Jan T. Soller,Katharina A. Sterenczak,Saskia Willenbrock,Susanne Winkler,Martina Dorsch,Nicola Reimann-Berg,Hans J. Hedrich,Jörn Bullerdiek,Ingo Nölte	2008	18
20	Comparison of the Human and Canine Cytokines IL-1(α/β) and TNF-α to Orthologous Other Mammalians Journal of Heredity ·Jan T. Soller,Hugo Murua-Escobar,Saskia Willenbrock,Miriam C Janssen,N. Eberle,Jörn Bullerdiek,Ingo Nölte	2007	18

About Saskia Willenbrock

Saskia Willenbrock is a scholar working on Equine, Clinical Biochemistry and Cancer Research, having authored 34 papers that have together received 565 indexed citations. Recurring topics across this work include Virus-based gene therapy research (8 papers), Veterinary Oncology Research (7 papers), Immunotherapy and Immune Responses (5 papers), Laser Material Processing Techniques (4 papers), Electrohydrodynamics and Fluid Dynamics (3 papers), RNA Interference and Gene Delivery (3 papers), MicroRNA in disease regulation (3 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Equine (17 citations), Clinical Biochemistry (45 citations) and Cancer Research (80 citations). Saskia Willenbrock has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Hugo Murua Escobar, Ingo Nölte, Alexander Heisterkamp, Siegfried Wagner, Jörn Bullerdiek, Anaclet Ngezahayo, N. Eberle, Christian Junghanß, Marion Hewicker‐Trautwein and W. Ertmer. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and Optics Express.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact